These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 14210922

  • 1. [HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
    NAYRAC P, ARNOTT G, MILBLED G.
    Lille Med; 1964 Oct; 9():765-8. PubMed ID: 14210922
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [TREATMENT OF CHRONIC PSYCHOSES WITH HALOPERIDOL (R 1625)].
    LUNA NE.
    Sem Med; 1964 Apr 23; 124():973-5. PubMed ID: 14183757
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TREATMENT OF DYSKINESIAS INCLUDING HUNTINGTON'S CHOREA WITH THIOPROPAZATE AND R-1625.
    VAISBERG M, SAUNDERS JC.
    Dis Nerv Syst; 1963 Aug 23; 24():499-500. PubMed ID: 14051622
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [THERAPEUTIC EXPERIENCES WITH "MASSIVE" DOSES OF CHLORPROMAZINE].
    DENCKER SJ, JANSSON L.
    Nord Med; 1965 Jun 10; 73():561-3. PubMed ID: 14292325
    [No Abstract] [Full Text] [Related]

  • 10. CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
    Faurbye A, Clausen J.
    Acta Psychiatr Scand; 1964 Jun 10; 40(1):107-16. PubMed ID: 14211377
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [CLINICO-THERAPEUTIC TRIALS WITH DIPIPERON, A NEW BUTYROPHENONE SERIES DERIVATIVE].
    SCHWARZ H, KRUEGER HJ, JUENEMANN HJ.
    Acta Neurol Psychiatr Belg; 1964 Apr 10; 64():401-12. PubMed ID: 14176013
    [No Abstract] [Full Text] [Related]

  • 13. A STUDY OF THE VALUE OF HALOPERIDOL IN THE MANAGEMENT AND TREATMENT OF SCHIZOPHRENIC AND MANIC PATIENTS.
    REES L, DAVIES B.
    Int J Neuropsychiatry; 1965 Apr 10; 1():263-6. PubMed ID: 14309092
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. OBSERVATIONS ON HUNTINGTON'S CHOREA IN CHILDHOOD.
    MARKHAM CH, KNOX JW.
    J Pediatr; 1965 Jul 10; 67():46-57. PubMed ID: 14301558
    [No Abstract] [Full Text] [Related]

  • 16. [C.B. 8089 (FLUORIZED BUTYROPHENONE) IN STATES OF PSYCHOMOTOR AGITATION AND IN CHARACTER DISORDERS AT ALL AGES (EXCEPT CHILDHOOD)].
    CHATAGNON PA, CHATAGNON C.
    Ann Med Psychol (Paris); 1964 May 10; 122():809-16. PubMed ID: 14150706
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [THE TREATMENT OF MANIAS AND MANIC STATES WITH HALOPERIDOL].
    BOHACEK N.
    Wien Med Wochenschr; 1964 Jan 25; 114():76-9. PubMed ID: 14124492
    [No Abstract] [Full Text] [Related]

  • 19. [The use of butyrophenone preparations in Huntington's chorea].
    Escalar G, Majeron MA.
    Minerva Med; 1969 Jun 23; 60(50):2494-6. PubMed ID: 4240012
    [No Abstract] [Full Text] [Related]

  • 20. [OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL].
    GALINDEZ L, SANTOS MR, BOREL RO.
    Dia Med; 1963 Sep 12; 35():1435-6. PubMed ID: 14088362
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.